Safety Considerations for Visiting Primary Care Doctors

Rutgers expert warns not to delay visits and offers solutions to stay safe when seeing your physician in person

Newswise — The COVID-19 pandemic has left many people with chronic health conditions relying on telemedicine rather than seeing their doctor in person when necessary or putting off important visits entirely because they fear being infected.

Ann M. Nguyen, an assistant research professor at Rutgers Center for State Health Policy at the Institute for Health, Health Care Policy and Aging Research, who recently published a paper on safety measures at physician offices, discusses what people should know about visiting their doctor and why putting off appointments that need to be done in person could lead to other health problems.

What can patients do to assess the safety of their doctor’s office when making an appointment?
The physician’s office should be appointment-only and have clear safety protocols posted online, outside of their office or described over the phone. While making an appointment, the office staff should walk patients through those safety protocols, such as asking them to wear a mask to the in-person visit and to come alone unless a companion is necessary for their physical or emotional health. Staff should ask COVID-19 screening questions over the phone. Any information that can be collected over the phone or online, such as insurance information, should be done before the appointment.

What are doctors’ offices doing to ensure safety during in-person visits?
Contact is limited as much as possible. Intake forms are completed online or over the phone. Offices offer early-morning appointments for high-risk patients to lessen exposure, discourage or stop walk-in appointments and stagger in-person visits to allow time for rooms and equipment to be cleaned.

Patients wait outside or in their car until the doctor is ready to see them. While they wait, an office staff member asks COVID-19 screening questions and checks their temperature. The office staff member also offers to do part of the visit at the curbside or in the parking lot if possible, such taking blood pressure. If patients must go into a waiting room, the offices limit the number of people to allow for social distancing. During the visit, office staff and the doctor maintain a six-foot distance when possible. Equipment and rooms are marked as sanitized. Hand sanitizer is available. Everyone in the office is wearing personal protective equipment, including other patients.

What precautions should people take for lab work?
Patients should call labs before booking appointments since many have slowed response times and capacity or have focused on coronavirus testing. People with chronic conditions especially should ask the labs and/or their doctors for tips on the best times to visit and how the lab separates patients seeking routine lab work from those with appointments for coronavirus testing.

How have doctors’ offices otherwise restructured operations for safety?
Following every patient visit, the equipment and examination rooms are sanitized. To reduce contact, offices have set up patient portals for questions. Doctor’s office staff who can perform their jobs at home are not in the office. Also, since primary care clinics need to have a close pulse on their community, they can keep in direct communication with local and state health agencies to monitor evolving conditions.




Filters close

Showing results

110 of 5584
Released: 7-May-2021 1:40 PM EDT
There is no evidence that vaccines could cause harm to people who have recovered from COVID-19
Newswise

An article published by Robert F. Kennedy Jr.’s anti-vaccination organization and widely shared on social media questions the need of vaccinating those who’ve already recovered from COVID-19. The article says there’s a "potential risk of harm, including death" in getting the vaccines. We report this claim as false. There is no evidence that vaccinating people who had previously had COVID is resulting in an increased risk of adverse events.

Newswise: Abbott.jpg
Released: 7-May-2021 1:00 PM EDT
FSU expert available to discuss intellectual property and COVID-19 vaccines
Florida State University

By: Bill Wellock | Published: May 7, 2021 | 11:55 am | SHARE: President Joe Biden has expressed his support for a World Trade Organization proposal to waive intellectual property rights for COVID-19 vaccines.Florida State University law professor Frederick Abbott, the Edward Ball Eminent Scholar Professor of International Law, is available to comment on international intellectual property rights and global economic issues around the proposal.

access_time Embargo lifts in 2 days
Embargo will expire: 11-May-2021 11:00 AM EDT Released to reporters: 7-May-2021 1:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 11-May-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 7-May-2021 11:15 AM EDT
Asthma attacks plummeted among Black and hispanic/latinx individuals during the COVID-19 pandemic
Brigham and Women’s Hospital

Asthma attacks account for almost 50 percent of the cost of asthma care which totals $80 billion each year in the United States

access_time Embargo lifts in 2 days
Embargo will expire: 11-May-2021 11:00 AM EDT Released to reporters: 7-May-2021 10:40 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 11-May-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 7-May-2021 9:00 AM EDT
Navigating the COVID-19 crisis to prevent pressure injuries: Learning health system helped one hospital adapt and update care in real time
Wolters Kluwer Health: Lippincott

Early in the COVID-19 pandemic, healthcare systems scrambled to modify patient care processes – particularly when it came to strategies aimed at reducing the risk of hospital-related complications. A look at how one hospital applied its learning health system (LHS) framework to respond to a COVID-19-related increase in hospital-acquired pressure injuries (HAPIs) is presented in the May/June Journal for Healthcare Quality (JHQ), the peer-reviewed journal of the National Association for Healthcare Quality (NAHQ). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: Ultra-Fast COVID-19 Sensor Invented at Texas Tech Gets Boost Into International Markets
Released: 7-May-2021 8:55 AM EDT
Ultra-Fast COVID-19 Sensor Invented at Texas Tech Gets Boost Into International Markets
Texas Tech University

EviroTech LLC announced today (May 7) a $4 million investment into the company by 1701 Ventures GmbH of Göttingen, Germany, which will allow EviroTech to complete the final design, production startup and market introduction of its Ultra-Fast COVID-19 detection sensor.

Released: 7-May-2021 7:05 AM EDT
Rutgers Recruiting Participants for Pfizer COVID-19 Pediatric Vaccine Clinical Trial
Rutgers University-New Brunswick

Rutgers has been selected as a clinical trial site for the global Pfizer-BioNTech research study to evaluate the efficacy of its COVID-19 vaccine in children ages 6 months to 11 years. This is the third time Rutgers has served as a COVID-19 vaccine clinical trial site for pharmaceutical companies. Last fall, it conducted trials for Moderna and Johnson & Johnson.


Showing results

110 of 5584

close
2.41574